FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to therapy, dermatology, clinical laboratory diagnostics, and can be used to assess the effectiveness of treatment of patients with psoriatic arthritis. For this, on the day of admission and on the 30th day of treatment, venous blood is taken and the content of nitric oxide, alpha-1 acid glycoprotein, ceruloplasmin and haptoglobin is determined. The ratio of the value of each indicator obtained on the day of receipt to its value on the 30th day is calculated, the average value of the sum of the received ratios of all indicators. With an average value of 1.5 or more, the treatment is assessed as effective, with an average value of less than 1.5, the treatment is assessed as ineffective.
EFFECT: invention makes it possible to control the effectiveness of therapy for this category of patients and, if necessary, to timely adjust the management tactics.
1 cl, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
DIAGNOSTIC TECHNIQUE FOR TUBERCULOUS ARTHRITIS ACTIVITY | 2009 |
|
RU2424520C2 |
METHOD FOR ESTIMATING PSORIATIC ERYTHRODERMIA TREATMENT EFFECTIVENESS | 2005 |
|
RU2297004C1 |
METHOD FOR ASSESSING THE EFFECTIVENESS OF TREATMENT OF PSORIATIC ARTHRITIS USING ANTIOXIDANT SYSTEM PARAMETERS | 2021 |
|
RU2762105C1 |
METHOD FOR EVALUATING INFLAMMATORY PROCESS ACTIVITY AT PSORIASIS | 2005 |
|
RU2290645C1 |
METHOD FOR DETERMINING INDICATIONS TO BEGINNING OF RECEPTION OF GENETIC ENGINEERING BIOLOGICAL PREPARATIONS WITH INEFFECTIVENESS OF BASIC ANTI-INFLAMMATORY PREPARATIONS IN EARLY FORMS OF PSORIATIC ARTHRITIS | 2020 |
|
RU2731807C1 |
METHOD OF PREDICTING ACHIEVEMENT OF MINIMAL DISEASE ACTIVITY DURING THERAPY IN TREATMENT OF PATIENTS WITH PSORIATIC ARTHRITIS | 2022 |
|
RU2808550C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING TYPE 2 PSORIASIS IN POSTMENOPAUSAL WOMEN | 2018 |
|
RU2684287C1 |
METHOD FOR PREDICTING THE COURSE OF PSORIATIC ARTHRITIS | 2021 |
|
RU2765111C1 |
METHOD FOR RAPID ASSESSMENT OF AXIAL SKELETON INVOLVEMENT RISK IN EARLY FORMS OF PSORIATIC ARTHRITIS | 2020 |
|
RU2724276C1 |
METHOD FOR DETERMINING PSORIATIC ARTHRITIS ACTIVITY | 2020 |
|
RU2746884C1 |
Authors
Dates
2021-12-15—Published
2021-05-25—Filed